Rotating Gamma System Irradiation: A Promising Treatment for Low-grade Brainstem Gliomas.

AIM: To evaluate the role of rotating gamma system (RGS) radiosurgery for low-grade brainstem gliomas.

PATIENTS AND

METHODS

Thirty-seven patients undergoing RGS radiosurgery at the Bach Mai Hospital Hanoi for low-grade brainstem glioma were included in this prospective interventional study. The median RGS dose was 12 Gy (range=8-16 Gy). Endpoints included response to RGS radiosurgery given as change in glioma size (maximum diameter), survival and adverse events. Follow-up was performed for 36 months. Three dose-groups (<13, 13-14 and >14 Gy) were compared for survival.

RESULTS

Mean glioma size decreased from 1.87 cm before RGS irradiation to 1.15 cm at 36 months. Mean survival was 39.5 months. Mean survival after <13, 13-14 and >14 Gy were 22.7, 66.7 and 49 months, respectively (p<0.05). Adverse events, mainly reduced appetite, sleep disturbances, headache and edema, were not associated with RGS dose and were easily managed.

CONCLUSION

RGS radiosurgery led to promising results with acceptable toxicity in patients with low-grade brainstem gliomas.